Abstract
Being an emerging field of “omics” research, metabonomics has been increasingly used in toxicological studies mostly because this technology has the ability to provide more detailed information to elucidate mechanism of toxicity. As an interdisciplinary field of science, metabonomics combines analytical chemistry, bioinformatics, statistics, and biochemistry. When applied to toxicology, metabonomics also includes aspects of patho-biochemistry, systems biology, and molecular diagnostics. During a toxicological study, the metabolic changes over time and dose after chemical treatment can be monitored. Therefore, the most important use of this emerging technology is the identification of signatures of toxicity—patterns of metabolic changes predictive of a hazard manifestation. This chapter summarizes the current state of metabonomics technology and its applications in various areas of toxicological studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hartung T (2009) Toxicology for the twenty-first century. Nature 460:208–212
Davis M, Boekelheide K, Boverhof DR et al (2013) The new revolution in toxicology: the good, the bad, and the ugly. Ann N Y Acad Sci 1278:11–24
Hartung T, McBride M (2011) Food for thought… on mapping the human toxome. ALTEX 28:83–93
Kleensang A, Maertens A, Rosenberg M et al. (2014) t4 Workshop Report: Pathways of toxicity. ALTEX 31:53–61
Hartung T (2010) Food for thought… on alternative methods for chemical safety testing. ALTEX 27:3–14
Ramirez T, Daneshian M, Kamp H et al (2012) Metabolomics in toxicology and preclinical research. ALTEX 30:209–225
Hartung T (2008) Food for thought… on animal tests. ALTEX 25:3–9
Bracken MB (2009) Why animal studies are often poor predictors of human reactions to exposure. J R Soc Med 102:120–122
Bucher JR (2002) The national toxicology program rodent bioassay. Ann N Y Acad Sci 982:198–207
Bottini AA, Hartung T (2009) Food for thought… on economics of animal testing. ALTEX 26:3–16
Basketter DA, Clewell H, Kimber I et al (2012) t (4) report a roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. ALTEX 29:3–91
Stevens JL (2006) Future of toxicology mechanisms of toxicity and drug safety: where do we go from here? Chem Res Toxicol 19:1393–1401
Hartung T (2013) Food for thought… look back in anger: what clinical studies tell us about preclinical work. ALTEX 30:275
Hartung T, Luechtefeld T, Maertens A et al (2013) Food for thought… integrated testing strategies for safety assessments. ALTEX 30:3
Hartung T, van Vliet E, Jaworska J et al (2012) Food for thought…systems toxicology. ALTEX 29:119
van Vliet E (2011) Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century. ALTEX 28:17
Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85:809–822
Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189
Nicholson JK, Connelly J, Lindon JC et al (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161
Holmes E, Wilson ID, Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134:714–717
Nicholson JK (2006) Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2:52. doi:10.1038/msb4100095
Fiehn O (2002) Metabolomics: the link between genotypes and phenotypes. Plant Mol Biol 48:155–171
Ramsden JJ (2004) Metabolomics and metabonomics. In: Bioinformatics: an introduction. Springer Netherlands, p 221–226. doi:10.1007/978-1-4020-2950-9_15
Friedrich N (2012) Metabolomics in diabetes research. J Endocrinol 215:29–42
Koal T, Deigner HP (2010) Challenges in mass spectrometry based targeted metabolomics. Curr Mol Med 10:216–226
Wang W, Zhang W, Liu J et al (2013) Metabolomic changes in follicular fluid induced by soy isoflavones administered to rats from weaning until sexual maturity. Toxicol Appl Pharmacol 269:280–289
Crockford DJ, Maher AD, Ahmadi KR et al (2008) 1H NMR and UPLC-MSE statistical heterospectroscopy: characterization of drug metabolites (Xenometabolome) in epidemiological studies. Anal Chem 80:6835–6844
Dunn WB, Ellis DI (2005) Metabolomics: current analytical platforms and methodologies. Trends Anal Chem 24:285–294
Dunn WB, Bailey NJ, Johnson HE (2005) Measuring the metabolome: current analytical technologies. Analyst 130:606–625
Bouhifd M, Hartung T, Hogberg HT et al (2013) Review: toxicometabolomics. J Appl Toxicol 33:1365–1383
Southam AD, Lange A, Hines A et al (2011) Metabolomics reveals target and off-target toxicities of a model organophosphate pesticide to roach (Rutilus rutilus): implications for biomonitoring. Environ Sci Technol 45:3759–3767
Begriche K, Massart J, Robin MA et al (2011) Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54:773–794
Lin S, Yang Z, Liu H et al (2011) Metabolomic analysis of liver and skeletal muscle tissues in C57BL/6J and DBA/2J mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Biosyst 7:1956–1965
Li F, Lu J, Ma X (2011) Profiling the reactive metabolites of xenobiotics using metabolomic technologies. Chem Res Toxicol 24:744–751
Griffiths WJ, Koal T, Wang Y et al (2010) Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 49:5426–5445
Chen J, Zhang X, Cao R et al (2011) Serum 27-nor-5beta-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J Proteome Res 10:2625–2632
Lucio M, Fekete A, Weigert C et al (2010) Insulin sensitivity is reflected by characteristic metabolic fingerprints: a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 5:e13317
Issaq HJ, Waybright TJ, Veenstra TD (2011) Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis 32:967–975
Woo HM, Kim KM, Choi MH et al (2009) Mass spectrometry based metabolomic approaches in urinary biomarker study of women’s cancers. Clin Chim Acta 400:63–69
Wang X, Zhang A, Han Y et al (2012) Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 11:370–380
Hollywood K, Brison DR, Goodacre R (2006) Metabolomics: current technologies and future trends. Proteomics 6:4716–4723
Kim HK, Choi YH, Verpoorte R (2011) NMR-based plant metabolomics: where do we stand, where do we go? Trends Biotechnol 29:267–275
Scalbert A, Brennan L, Fiehn O et al (2009) Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 5:435–458
Wishart DS (2008) Quantitative metabolomics using NMR. Trends Anal Chem 27:228–237
Hanzlik RP, Bhatia P, Stitt R et al (1980) Biotransformation and excretion of methylcyclopentadienyl manganese tricarbonyl in the rat. Drug Metab Dispos 8:428–433
Fukuhara K, Ohno A, Ando Y et al (2011) A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity. Drug Metab Pharmacokinet 26:399–406
Liu X, Zhang L, You L et al (2011) Toxicological responses to acute mercury exposure for three species of Manila clam Ruditapes philippinarum by NMR-based metabolomics. Environ Toxicol Pharmacol 31:323–332
Barba I, Fernandez-Montesinos R, Garcia-Dorado D et al (2008) Alzheimer’s disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. J Cell Mol Med 12:1477–1485
Neerathilingam M, Volk DE, Sarkar S et al (2010) 1H NMR-based metabonomic investigation of tributyl phosphate exposure in rats. Toxicol Lett 199:10–16
Beger RD, Sun J, Schnackenberg LK (2010) Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243:154–166
Serkova NJ, Van Rheen Z, Tobias M et al (2008) Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 295:L152–L161
Griffin JL, Kauppinen RA (2007) A metabolomics perspective of human brain tumours. FEBS J 274:1132–1139
Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653–683
Roux A, Lison D, Junot C et al (2011) Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clin Biochem 44:119–135
Patterson AD, Lanz C, Gonzalez FJ et al (2010) The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev 29:503–521
Singh OV (2006) Proteomics and metabolomics: the molecular make-up of toxic aromatic pollutant bioremediation. Proteomics 6:5481–5492
Chen C, Gonzalez FJ, Idle JR (2007) LC-MS-based metabolomics in drug metabolism. Drug Metab Rev 39:581–597
Crockford DJ, Holmes E, Lindon JC et al (2006) Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem 78:363–371
West PR, Weir AM, Smith AM et al (2010) Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol Appl Pharmacol 247:18–27
Wang J, Reijmers T, Chen L et al (2009) Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics. Metabolomics 5:407–418
Dunn WB, Wilson ID, Nicholls AW et al (2012) The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 4:2249–2264
Fan TW-M (2012) Considerations of sample preparation for metabolomics investigation. In: the handbook of metabolomics. Springer, p 7–27
Lafaye A, Junot C, Gall BRL et al. (2003) Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity. Rapid Commun Mass Spectrom 17:2541–2549
Chen C, Krausz KW, Idle JR et al (2008) Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J Biol Chem 283:4543–4559
Laaksonen R, Katajamaa M, Päivä H et al (2006) A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS One 1:e97
Teng Q, Huang W, Collette TW et al (2009) A direct cell quenching method for cell-culture based metabolomics. Metabolomics 5:199–208
Prasad Maharjan R, Ferenci T (2003) Global metabolite analysis: the influence of extraction methodology on metabolome profiles of Escherichia coli. Anal Biochem 313:145–154
Jackson JE (2005) A user’s guide to principal components. John Wiley & Sons, New York, NY
Kaufman L, Rousseeuw PJ (2009) Finding groups in data: an introduction to cluster analysis. John Wiley & Sons, New York, NY
Lutz U, Lutz RW, Lutz WK (2006) Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender. Anal Chem 78:4564–4571
Trygg J, Wold S (2002) Orthogonal projections to latent structures (O‐PLS). J Chemometrics 16:119–128
Shockcor JP, Holmes E (2002) Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem 2:35–51
Robertson DG, Reily MD, Sigler RE et al (2000) Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 57:326–337
Van Vliet E, Morath S, Eskes C et al (2008) A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology 29:1–12
Boudonck KJ, Mitchell MW, Német L et al (2009) Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 37:280–292
Vangala S, Tonelli A (2007) Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity? AAPS J 9:E284–E297
Nicholls AW, Holmes E, Lindon JC et al (2001) Metabonomic investigations into hydrazine toxicity in the rat. Chem Res Toxicol 14:975–987
Sieber M, Hoffmann D, Adler M et al (2009) Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci 109:336–349
Antoine D, Mercer A, Williams D et al (2009) Mechanism-based bioanalysis and biomarkers for hepatic chemical stress. Xenobiotica 39:565–577
Lujan R, Shigemoto R, Lopez-Bendito G (2005) Glutamate and GABA receptor signalling in the developing brain. Neuroscience 130:567–580
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Zhao, L., Hartung, T. (2015). Metabonomics and Toxicology. In: Bjerrum, J. (eds) Metabonomics. Methods in Molecular Biology, vol 1277. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2377-9_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2377-9_15
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2376-2
Online ISBN: 978-1-4939-2377-9
eBook Packages: Springer Protocols